Citicoline Market

Citicoline (cytidine diphosphocholine, CDP-choline) is a novel nutrient with a broad spectrum of benefits for conditions associated with symptoms of neurological dysfunction. An endogenous compound, citicoline is an essential intermediate in the synthesis of cell membrane phospholipids and its formation is the rate-limiting step in phosphatidylcholine synthesis. It plays several important roles in human physiology, including enhancement of structural integrity and signaling for cell membranes, support of acetylcholine synthesis, and synthesis of betaine, a methyl donor. Citicoline provides the brain with a source of choline and cytidine, which are efficiently used in the Kennedy cycle to generate phospholipids. It is able to attenuate the production of free radicals in ischemic conditions, while it also stimulates glutathione synthesis and the activity of glutathione reductase. Studies in animals and humans provide evidence of citicoline s ability to promote learning and memory and improve cognitive impairment in Alzheimer s and Parkinson s disease, as well as in victims of mild to moderate stroke and cerebral ischemia. Citicoline administration may also reduce the duration of coma and the severity of mental and motor deficits associated with traumatic head injuries.

As a medicine, it is taken by mouth as a supplement or given by IV or as a shot. Citicoline is used for Alzheimer's disease and other types of dementia, head trauma, cerebrovascular disease such as stroke, age-related memory loss, Parkinson's disease, attention deficit-hyperactive disorder (ADHD), and glaucoma.

Citicoline was originally developed in Japan for stroke. It was later introduced as a prescription drug in many European countries. In these countries it is now frequently prescribed for thinking problems related to circulation problems in the brain. In the US, citicoline is marketed as a dietary supplement.

Citicoline Market contains market size and forecasts of Citicoline in global, including the following market information:

• Global Citicoline Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Citicoline Market Sales, 2017-2022, 2023-2028, (Ton)
• Global top five Citicoline companies in 2021 (%)

The global Citicoline market was valued at 304.6 million in 2021 and is projected to reach US$ 751.9 million by 2028, at a CAGR of 13.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Citicoline include Union Korea Pharm, Century Pharma, Invision Medi Sciences, Rasco Life Sciences, RPG Life Sciences Ltd, Chemo Biological, Harbin Pharm. Group Sanjing Pharmaceutical and Innova, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Citicoline manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Citicoline Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Ton)

Global Citicoline Market Segment Percentages, by Type, 2021 (%)

• Injection
• Tablets
• Capsule

Global Citicoline Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Ton)

Global Citicoline Market Segment Percentages, by Application, 2021 (%)

• Pharma
• Non-pharma

Global Citicoline Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Ton)

Global Citicoline Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Citicoline revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Citicoline revenues share in global market, 2021 (%)
• Key companies Citicoline sales in global market, 2017-2022 (Estimated), (Ton)
• Key companies Citicoline sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Union Korea Pharm
• Century Pharma
• Invision Medi Sciences
• Rasco Life Sciences
• RPG Life Sciences Ltd
• Chemo Biological
• Harbin Pharm. Group Sanjing Pharmaceutical
• Innova